Cannabinoids offer hope in medical treatment

The cannabis plant contains an abundance of chemical compounds called cannabinoids.

They are naturally occurring chemicals responsible for the effects of cannabis consumption.

These effects can be both positive and negative. Scientists don’t fully understand how all of the cannabinoids affect us. The two most well-known are tetrahydrocannabinol (THC) and cannabidiol (CBD), but there are several less-abundant compounds that are gaining more recognition. THC is a psychoactive compound that is responsible for the high sensation or euphoria associated with consumption. Levels of THC continue to increase as growers produce hybrids with greater concentrations of it. CBD avoids the high sensation while offering significant benefits. It is used to treat pain and nausea, alleviate migraines and prevent seizures. Cannabinol (CBN) is gaining attention for easing symptoms and side effects of neurological conditions such as seizures, muscle stiffness and epilepsy. Tetrahydrocannabinolic acid (THCA) has a lot in common with THC but avoids the psychoactive effects. It is showing promise in reducing inflammation due to arthritis and may also help to treat Parkinson’s disease and ALS. Cannabigerol (CBG) is believed to reduce anxiety and help with symptoms of depression, PTSD and obsessive-compulsive disorder. There is still a long list of cannabinoids that are still a mystery. Many believe that understanding the effects of each of these cannabinoids and how they work together is the key to unlocking therapeutic potential. Researchers are just beginning to explore the advantages of the entourage effect. This where different cannabinoids perform more effectively in partnership than on their own. From anti-cancer properties to slowing down the symptoms of Alzheimers, cannabis offers hope to those suffering from a wide range of medical ailments.